DE69414947D1 - Dialyselösung zur extrakorporalen Hemodialyse - Google Patents

Dialyselösung zur extrakorporalen Hemodialyse

Info

Publication number
DE69414947D1
DE69414947D1 DE69414947T DE69414947T DE69414947D1 DE 69414947 D1 DE69414947 D1 DE 69414947D1 DE 69414947 T DE69414947 T DE 69414947T DE 69414947 T DE69414947 T DE 69414947T DE 69414947 D1 DE69414947 D1 DE 69414947D1
Authority
DE
Germany
Prior art keywords
dialysis solution
renal
composition
extracorporeal hemodialysis
nephrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69414947T
Other languages
English (en)
Other versions
DE69414947T2 (de
Inventor
Kazumi Ogata
Takahiro Sakaue
Noriko Saito
Sachiko Matsuura
Rie Nagao
Shinya Ogino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69414947D1 publication Critical patent/DE69414947D1/de
Publication of DE69414947T2 publication Critical patent/DE69414947T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12Magnesium silicate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287Dialysates therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69414947T 1993-09-10 1994-09-07 Dialyselösung zur extrakorporalen Hemodialyse Expired - Fee Related DE69414947T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22538993 1993-09-10

Publications (2)

Publication Number Publication Date
DE69414947D1 true DE69414947D1 (de) 1999-01-14
DE69414947T2 DE69414947T2 (de) 1999-07-08

Family

ID=16828600

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69414947T Expired - Fee Related DE69414947T2 (de) 1993-09-10 1994-09-07 Dialyselösung zur extrakorporalen Hemodialyse

Country Status (8)

Country Link
US (1) US5474992A (de)
EP (1) EP0643969B1 (de)
KR (1) KR950007845A (de)
AT (1) ATE173928T1 (de)
CA (1) CA2129509A1 (de)
DE (1) DE69414947T2 (de)
ES (1) ES2124348T3 (de)
TW (1) TW298566B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2244535A1 (en) * 1995-05-15 2000-01-30 Avon Products, Inc. Novel uses for ascorbyl-phosphoryl-cholesterol in topical compositions
US6162450A (en) * 1995-05-15 2000-12-19 Avon Products, Inc. Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
US6436969B1 (en) 1995-09-12 2002-08-20 Kansas University Medical Center Research Institute Inc. Dialysis solutions and methods
JPH09194375A (ja) * 1996-01-17 1997-07-29 Senju Pharmaceut Co Ltd 免疫抑制作用増強剤
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
US7670491B2 (en) * 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
WO2000051987A2 (en) 1999-03-05 2000-09-08 Kansas University Medical Center Inhibitors of advanced, post-amadori glycosylation reactions
EP2052751A3 (de) * 1999-09-22 2009-06-03 Advanced Renal Technologies Anwendung eines Dialysats mit hohem Zitratgehalt
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
EP1420797A4 (de) 2001-07-27 2005-03-02 Vital Health Sciences Pty Ltd Hauttherapie unter verwendung von phosphatderivaten von elektronentransfermitteln
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
SE0400523D0 (sv) 2004-03-01 2004-03-01 Gambro Lundia Ab A medical solution, a method for producing said medical solution and use thereof
WO2005084678A1 (en) 2004-03-03 2005-09-15 Vital Health Sciences Pty Ltd Alkaloid formulations
KR101037152B1 (ko) * 2004-04-23 2011-05-26 엘지전자 주식회사 세탁기의 제어 방법
SE0402507D0 (sv) 2004-10-14 2004-10-14 Gambro Lundia Ab Medicinsk lösning, förfarande för framställning och användning därav
EP1861091B1 (de) * 2005-03-03 2013-12-11 Vital Health Sciences Pty Ltd. Verbindungen mit lipidsenkenden eigenschaften
ES2557475T3 (es) 2005-06-17 2016-01-26 Vital Health Sciences Pty Ltd. Un portador que comprende uno o más derivados di- y/o monofosfato de agentes de transferencia de electrones
WO2011094814A1 (en) 2010-02-05 2011-08-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
ES2829386T3 (es) 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
EP2685992A4 (de) 2011-03-15 2014-09-10 Phosphagenics Ltd Aminochinoline als kinasehemmer
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
CN110662733A (zh) 2016-12-21 2020-01-07 埃维科生物技术有限公司 方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25859A (en) * 1988-01-11 1991-12-02 Takeda Chemical Industries Ltd Composition for treatment of ischemic disorder
ES2058891T3 (es) * 1989-02-02 1994-11-01 Senju Pharma Co Preparacion liquida para perfusion intraocular.
JP2854631B2 (ja) * 1989-11-21 1999-02-03 千寿製薬株式会社 糖尿病合併症および老化によって引き起こされる疾患の予防・治療剤
ATE149682T1 (de) * 1991-12-04 1997-03-15 Bertin & Cie Verfahren und vorrichtung zur optischen ferndetektion eines sich in einem beobachteten raumgebiet befindenden gases

Also Published As

Publication number Publication date
ATE173928T1 (de) 1998-12-15
KR950007845A (ko) 1995-04-15
TW298566B (de) 1997-02-21
ES2124348T3 (es) 1999-02-01
US5474992A (en) 1995-12-12
EP0643969A3 (de) 1996-03-13
DE69414947T2 (de) 1999-07-08
EP0643969B1 (de) 1998-12-02
EP0643969A2 (de) 1995-03-22
CA2129509A1 (en) 1995-03-11

Similar Documents

Publication Publication Date Title
DE69414947D1 (de) Dialyselösung zur extrakorporalen Hemodialyse
BR0014179A (pt) Modernos derivados de ácido aminodicarboxìlico com propriedades farmacêuticas
TNSN01035A1 (fr) Derives d'ethers de pyrazole nouveaux, et compositions pharmaceutiques les contenant.
TNSN98036A1 (fr) Derives d'acide hexanoique nouveaux
DE60024415D1 (de) Die glycin-betain für seine antithrombotische verwendung
BR9910122A (pt) Compostos amidina
HRP20050843A2 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds
DE69024826D1 (de) Aza-Macrozyklen und Verfahren zu deren Herstellung
SI21169B (sl) Nova uporaba peptidnega razreda spojine za zdravljenje alodinije ali drugih razliäśnih vrst kroniäśne ali fantomske boleäśine
TNSN01124A1 (fr) Derives de 1,4-dihydropyridine nouveaux , servant d'antagonistes de la bradykinine, et compositions les contenant
BR0013065A (pt) Método e composto para tratar de uma doença associada com recrutamento e/ ou ativação aberrante de leucócitos
EP0276376A3 (de) Anordnung zur Vorbereitung einer Flüssigkeit für eine medizinische Behandlung
NO20040520L (no) Heterocykliske derivater som inhiberer faktor XA
NO20005497L (no) Heterocykliske derivater som inhiberer faktor Xa
ATE187642T1 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
DE69923444D1 (de) Heterozyklische verbindungen mit faktor xa hemmender wirkung
DK1289535T3 (da) Apoptotiske enheder til anvendelse ved behandling af neurodegenerative og andre neurologiske sygdomme
ATE290384T1 (de) Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen
DE60108130D1 (de) Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten
JP4390023B2 (ja) 過酢酸組成物
AR043003A1 (es) Compuestos (benzoimidazol-2-il) fenilaminas n-sustituidas, procedimiento para su preparacion, su uso como farmacos o como ayuda en diagnostico, y los medicamentos que las contienen
Oakley et al. The use of dialysis bath fluid as a vehicle for a drug with a narrow therapeutic index—Lithium chloride
KR900013956A (ko) 디메르캅토숙신산(dmsa)으로 규소를 감소시키는 방법
ATE464051T1 (de) Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz
Baloch et al. Nephritis and charcot-marie-tooth disease: an unusual association

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee